NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed